Prognostic value of using FeNO to guide step-down treatment decisions in asthma
<p><strong>Introduction:</strong> Use of fractional exhaled nitric oxide (FeNO) is recommended for asthma diagnosis but its role in guiding safe reduction of inhaled corticosteroids (ICS) is unclear.</p> <p><strong>Aims and objectives:</strong> To assess the...
| Päätekijät: | , , , , , , |
|---|---|
| Aineistotyyppi: | Conference item |
| Julkaistu: |
European Respiratory Society
2018
|